MedPath

Prediction of REsPonse to Antipsychotics using electRoEncephalography

Recruiting
Conditions
Psychotic illness
Schizophrenia
10039628
Registration Number
NL-OMON52737
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

- Age between 16 and 55 years old
- Psychotic episode
- Patients who are going to start or recently have started antipsychotic
treatment (<2
weeks prior to baseline visit)
- The participant needs to understand the study and is able to provide written
informed consent.

Exclusion Criteria

- Coercive measures. With exception of zorg machtiging if a patient wants to
start with antipsychotics voluntarily and the patient is competent of making
decisions.
- A history of mental retardation
- Organic brain damage
- Organic psychosis
- Patients who are pregnant or patients who are breastfeeding.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>For the primary outcome, patients will be divided into a responder and a<br /><br>non-responder group based on the Positive and Negative Symptoms Scale (PANSS)<br /><br>scores and remission criteria as defined by Andreasen and others.<br /><br><br /><br><br /><br><br /><br><br /><br>*</p><br>
Secondary Outcome Measures
NameTimeMethod
<p> Secondary outcomes include improvement on questionnaires for the quality of<br /><br>life, general and physical health and functional outcome. Tertiary outcome<br /><br>includes continuous changes in psychosis symptom levels as measured by the<br /><br>PANSS.<br /><br><br /><br></p><br>
© Copyright 2025. All Rights Reserved by MedPath